Vaxcyte
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -5,854 | 4,989 | ||
EBITDA | -292,495 | -314,768 | -234,574 | -209,766 |
EBIT | -295,497 | -320,622 | -246,507 | -212,830 |
Net Income | -284,302 | -320,622 | -246,507 | -212,830 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -532,464 | -295,419 | -219,264 | -155,351 |
Cash | 183,190 | 260,843 | 173,959 | 281,080 |
Basic Shares | 144,494 | 139,506 | 136,089 | 136,196 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -15,845 | -75,000 | -9,196 | |
EBITDA | -741,768 | -448,082 | -392,095 | -214,030 |
EBIT | -766,628 | -463,927 | -402,266 | -223,483 |
Net Income | -766,628 | -463,927 | -402,266 | -223,485 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -669,290 | -475,054 | -364,667 | -176,438 |
Cash | 173,959 | 387,878 | 397,451 | 834,657 |
Basic Shares | 136,089 | 121,997 | 97,157 | 64,877 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$1.97 |
2026-03-31 | -$2.30 |
2025-12-31 | -$1.80 |
2025-09-30 | -$1.56 |